Prevalence and clinical significance of antibodies to citrullinated fibrinogen (ACF) in Chinese patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 26, Issue 9, 2007, Pages 1505-1512

  Zhao, Yi ^a   Tian, Xin ^b   Li, Zhanguo ^a  

^a PEKING UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Citrullination; Fibrinogen; Rheumatoid arthritis

Indexed keywords

ANTIPERINUCLEAR FACTOR; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FIBRINOGEN; IMMUNOGLOBULIN M; KERATIN ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHINA; CITRULLINE; COHORT STUDIES; FEMALE; FIBRINOGEN; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC;

EID: 34547575872     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0544-y     Document Type: Article

References (30)

1. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS et al (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236-243 236-243
2. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux JJ, Serre G (1995) The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 95:2672-2679
3. Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux JJ, Cantagrel A et al (1998) Immunoblotting detection of autoantibodies to human epidermis filaggrin: A new diagnostic test for rheumatoid arthritis. J Rheumatol 25:838-846
4. Slack SL, Mannik M, Dale BA (1998) Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol 25:847-851
5. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C et al (1999) The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 162:585-594
6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273-281
7. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155-163
8. Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197-204
9. Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F (2003) Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis. J Rheumatol 30:1451-1455
10. Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R (2005) Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol 35:1643-1652
11. Dejaco C, Klotz W, Larcher H, Duftner C, Schirmer M, Herold M (2006) Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis. Arthritis Res Ther 8:R119
12. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T et al (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166:4177-4184
13. Vander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A et al (2006) Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther 8:R122
14. Nielen MM, van der Horst AR, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, Aarden L et al (2005) Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis 64:1199-1204
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
16. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277
17. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601-1610
18. Nogueira L, Sebbag M, Vincent C, Arnaud M, Fournie B, Cantagrel A et al (2001) Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann Rheum Dis 60:882-887
19. Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K (2005) Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 333:418-426
20. van der Heijde D (1999) How to read radiographs according to the Sharp/ van der Heijde method. J Rheumatol 26:743-745
21. Van Reil PL (1994) Disease assessment and outcome in rheumatoid arthritis. Rheumatol Eur 23:128-129
22. Choi SW, Lim MK, Shin DH, Park JJ, Shim SC (2005) Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis. J Korean Med Sci 20:473-478
23. Samanci N, Ozdem S, Akbas H, Mutlu D, Gultekin M, Arman M et al (2005) Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis. J Natl Med Assoc 97:1120-1126
24. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA (2002) Diagnostic tests for rheumatoid arthritis: Comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatol (Oxf) 41:809-814
25. Raza K, Breese M, Nightingale P, Kumar K, Potter T, Carruthers DM et al (2005) Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 32:231-238
26. Gao IK, Haas-Wohrle A, Mueller KG, Lorenz HM, Fiehn C (2005) Determination of anti-CCP antibodies in patients with suspected rheumatoid arthritis: Does it help to predict the diagnosis before referral to a rheumatologist? Ann Rheum Dis 64:1516-1517
27. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089-1093
28. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A et al (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62:120-126
29. Kastbom A, Strandberg G, Lindroos A, Skogh T (2004) Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 63:1085-1089
30. McCluskey J, Farris AD, Keech CL, Purcell AW, Rischmueller M, Kinoshita G et al (1998) Determinant spreading: Lessons from animal models and human disease. Immunol Rev 164:209-229